Anti-obesity Prescription Drugs Market Research Report by Drug Class (Bupropion and Naltrexone, Liraglutide, Lorcaserin, Orlistat, and Phentermine and Topiramate), by Age Group (Adult and Pediatric), by Distribution Channel - Global Forecast to 2025 - Cumulative Impact of COVID-19 The Global Anti-obesity Prescription...
Consumer health in Slovakia is expected to show considerable resilience in response to the COVID-19 pandemic. Despite troubling economic circumstances, many consumers saw consumer health products as indispensable and continued to buy them despite decreasing incomes. Initial stockpiling in March did cause some product shortages, particularly...
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Review, H2 2020 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Basal Cell Carcinoma - Pipeline Review, H2 2020, provides an overview of the Basal Cell Carcinoma (Oncology) pipeline landscape. Basal cell carcinoma...
PharmaVitae explores Biogen’s prescription pharmaceutical performance and outlook over 2019–29. Snapshot Overview – Biogen’s prescription pharmaceutical business will see stable performance over the medium term. Key themes – [1] Biogen’s flagship MS portfolio – Tecfidera, Avonex, Plegridy, and Tysabri – remains...
The outbreak of Coronavirus (COVID-19) and the subsequent lockdown have had a strong effect on consumer health in Belgium. Thus, there have been significant switches from category to category, as well as one distribution channel to another due to strong restrictions on retailing. Consumer Health in Belgium report offers a comprehensive...
The North America Over the Counter (OTC) Drugs Market is anticipated to grow with a CAGR of 2.7%, during the forecast period. The OTC drugs market is innovation-driven and relies on the advent of innovative drugs for different disease complexities and vary in their degree of intensity, and efficacy. The product innovations in OTC drugs...
China’s demand for Sleep Disorder Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export,...
Filgrastim Biosimilars Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth provides the strategists, marketers and senior management with the critical information they need to assess the global Filgrastim Biosimilars market. Description: Where is the largest and fastest growing market...
The Europe patient controlled injectors market is expected to reach US$ 2,051.31 million by 2027 from US$ 835.44 million in 2019; it is expected to grow at a CAGR of 12.0% from 2020 to 2027. The increasing prevalence of chronic diseases and limitations on conventional drug delivery system boost the growth of the market.However, the preference...
The global osteoarthritis therapeutics market is projected to reach USD 11.0 billion by 2025 from USD 7.3 billion in 2020, at a CAGR of 8.7% from 2020 to 2025. The growth of this market is driven significant adoption of pain medications, increasing prevalence of osteoarthritis, growing population susceptible to osteoarthritis, and rising number...